SCHEMBL7708340

SCHEMBL7708340

CC1Oc2ccc(C(C)(NC(=O)OC(C)(C)C)c3cccs3)cc2N=C1N

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7704894 0.89 CTSK (0.31) ALDH1A1
SCHEMBL7710995 0.87 CTSK (0.32)
SCHEMBL7708015 0.85 AAK1 (0.32)
SCHEMBL7710854 0.84
SCHEMBL7711071 0.82 NAMPT (0.36) ALDH1A1
SCHEMBL7711428 0.81 PARP1 (0.39) ALDH1A1
SCHEMBL7705092 0.80 NPSR1 (0.36)
SCHEMBL7089637 0.80 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7708334 0.76 ALDH1A1 (0.32) ALDH1A1
SCHEMBL7713259 0.73 USP2 (0.39) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed